Home / Business / Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)

Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)

Copyright 2016 Zacks Investment Research

At a core of all we do is a clever joining to eccentric investigate and pity a essential discoveries with investors. This loyalty to giving investors a trade advantage led to a origination of a proven Zacks Rank stock-rating system. Since 1988 it has scarcely tripled a SP 500 with an normal benefit of +26% per year. These earnings cover a duration from 1988-2015 and were examined and attested by Baker Tilly Virchow Krause, LLP, an eccentric accounting firm.

Visit opening for information about a opening numbers displayed above.

Visit www.zacksdata.com to get a information and calm for your mobile app or website.

Real time prices by BATS. Delayed quotes by Sungard.

NYSE and AMEX information is during slightest 20 mins delayed. NASDAQ information is during slightest 15 mins delayed.

Article source: https://www.zacks.com/stock/news/228904/pfizer-to-buy-medivation-for-14b-boost-cancer-franchise-revised